Surya Biru Murni Acetylene Inkomsten in het verleden
Verleden criteriumcontroles 5/6
Surya Biru Murni Acetylene has been growing earnings at an average annual rate of 1.4%, while the Chemicals industry saw earnings growing at 9.7% annually. Revenues have been growing at an average rate of 12.3% per year. Surya Biru Murni Acetylene's return on equity is 4.3%, and it has net margins of 7.6%.
Belangrijke informatie
1.4%
Groei van de winst
-84.0%
Groei van de winst per aandeel
| Chemicals Groei van de industrie | 9.0% |
| Inkomstengroei | 12.3% |
| Rendement op eigen vermogen | 4.3% |
| Nettomarge | 7.6% |
| Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe Surya Biru Murni Acetylene geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Sep 24 | 127,925 | 9,688 | 42,798 | 0 |
| 30 Jun 24 | 121,277 | 9,147 | 37,630 | 0 |
| 31 Mar 24 | 115,759 | 5,844 | 35,778 | 0 |
| 31 Dec 23 | 113,370 | 4,733 | 34,528 | 0 |
| 30 Sep 23 | 112,283 | 1,774 | 37,106 | 0 |
| 30 Jun 23 | 110,510 | 1,264 | 37,824 | 0 |
| 31 Mar 23 | 105,531 | 2,417 | 37,450 | 0 |
| 31 Dec 22 | 103,643 | 4,484 | 36,905 | 0 |
| 30 Sep 22 | 100,288 | 12,214 | 35,898 | 0 |
| 30 Jun 22 | 94,761 | 10,995 | 33,487 | 0 |
| 31 Mar 22 | 94,048 | 9,050 | 32,419 | 0 |
| 31 Dec 21 | 88,261 | 7,414 | 30,334 | 0 |
| 30 Sep 21 | 81,370 | 5,495 | 26,381 | 0 |
| 31 Dec 20 | 74,268 | 5,305 | 22,435 | 0 |
| 31 Dec 19 | 71,962 | 4,620 | 23,261 | 0 |
| 31 Dec 18 | 66,635 | 5,199 | 20,640 | 0 |
Kwaliteitswinsten: SBMA has high quality earnings.
Groeiende winstmarge: SBMA's current net profit margins (7.6%) are higher than last year (1.6%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: SBMA's earnings have grown by 1.4% per year over the past 5 years.
Versnelling van de groei: SBMA's earnings growth over the past year (446.1%) exceeds its 5-year average (1.4% per year).
Winst versus industrie: SBMA earnings growth over the past year (446.1%) exceeded the Chemicals industry 12.6%.
Rendement op eigen vermogen
Hoge ROE: SBMA's Return on Equity (4.3%) is considered low.